Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neo Cremar is a South Korean biotechnology company specializing in the research, development, and manufacturing of functional food ingredients and nutraceuticals. The company is a global leader in the production of prebiotics, such as galacto-oligosaccharides (GOS), and functional peptides aimed at improving gut health, skin condition, and weight management. Neo Cremar leverages its proprietary fermentation and enzyme technology to supply high-quality ingredients to the global food, beverage, and dietary supplement industries. Their product portfolio includes innovative solutions like Mother's Oligo and Eatless, which are designed to address specific health concerns through nutritional intervention. The company is publicly traded and maintains a strong focus on clinical validation for its functional ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neo Cremar.